100 Nagog Park
Acton, MA 01720
United States
978 600 7000
https://www.insulet.com
版塊: Healthcare
行業: Medical Devices
全職員工: 3,000
名稱 | 頭銜 | 支付 | 行使價 | 出生年份 |
---|---|---|---|---|
Dr. James R. Hollingshead Ph.D. | President, CEO & Director | 2.88M | 無 | 1963 |
Mr. Mark Field | Senior VP & CTO | 954.14k | 無 | 1971 |
Mr. John Wodick Kapples | Senior VP & General Counsel | 1.02M | 無 | 1960 |
Ms. Shacey Petrovic | Director & Advisor | 28.57k | 無 | 1973 |
Mr. Eric Benjamin | Executive VP, Chief Product & Customer Experience Officer | 1.14M | 無 | 1983 |
Mr. Prem Singh | Senior Vice President of Global Operations | 無 | 無 | 1977 |
Ms. Laetitia Cousin | Senior VP of Regulatory Affairs, Quality Assurance & Compliance | 無 | 無 | 1976 |
Angela Geryak Wiczek | Senior Director of Corporate Communications | 無 | 無 | 無 |
Mr. Philip Hildale | Senior Vice President of Sales & Customer Care | 無 | 無 | 無 |
Mr. Andrew Isaacson | Senior VP of Strategy & Corporate Development | 無 | 無 | 無 |
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company's Omnipod platform includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5) which includes a proprietary AID algorithm embedded in the Pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless bluetooth communication; Omnipod DASH that features a bluetooth enabled Pod that is controlled by a smartphone-like Personal Diabetes Manager with a color touch screen user interface; and Omnipod GO, a standalone, wearable, insulin delivery system that provides a fixed rate of continuous rapid-acting insulin for 72 hours. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, Australia, and internationally. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
截至 2024年4月1日 止,Insulet公司 的 ISS 管治質素評分為 9。 Pillar 分數正在審核中:6;董事會:7;股東權利:10;現金賠償:8。